Skip to main content
Top
Published in: BMC Geriatrics 1/2018

Open Access 01-12-2018 | Research article

Psychosocial interventions for Alzheimer’s disease cognitive symptoms: a Bayesian network meta-analysis

Authors: Yuting Duan, Liming Lu, Juexuan Chen, Chunxiao Wu, Jielin Liang, Yan Zheng, Jinjian Wu, Peijing Rong, Chunzhi Tang

Published in: BMC Geriatrics | Issue 1/2018

Login to get access

Abstract

Background

Alzheimer disease (AD) is the most common type of dementia with cognitive decline as one of the core symptoms in older adults. Numerous studies have suggested the value of psychosocial interventions to improve cognition in this population, but which one should be preferred are still matters of controversy. Consequently, we aim to compare and rank different psychosocial interventions in the management of mild to moderate AD with cognitive symptoms.

Methods

We did a network meta-analysis to identify both direct and indirect evidence in relevant studies. We searched MEDLINE, EMBASE, PsycINFO through the OVID database, CENTRAL through the Cochrane Library for clinical randomized controlled trials investigating psychosocial interventions of cognitive symptoms in patients with Alzheimer disease, published up to August 31, 2017. We included trials of home-based exercise(HE), group exercise(GE), walking program(WP), reminiscence therapy(RT), art therapy(AT) or the combination of psychosocial interventions and acetylcholinesterase inhibitor (ChEIs). We extracted the relevant information from these trials with a predefined data extraction sheet and assessed the risk of bias with the Cochrane risk of bias tool. The outcomes investigated were Mini–Mental State Examination (MMSE) and compliance. We did a pair-wise meta-analysis using the fixed-effects model and then did a random-effects network meta-analysis within a Bayesian framework.

Results

We deemed 10 trials eligible, including 682 patients and 11 treatments. The quality of included study was rated as low in most comparison with Cochrane tools. Treatment effects from the network meta-analysis showed WP was better than control (SMD 4.89, 95% CI -0.07 to 10.00) while cognitive training and acetylcholinesterase inhibitor (CT + ChEIs) was significantly better than the other treatments, when compared with simple ChEIs treatment, assessed by MMSE. In terms of compliance, the pair-wise meta-analysis indicated that WP and HE are better than GE and AT, while CT + ChEIs, CST + ChEIs are better than other combined interventions.

Conclusion

Our study confirmed the effectiveness of psychosocial interventions for improving cognition or slowing down the progression of cognitive impairment in AD patients and recommended several interventions for clinical practice.
Appendix
Available only for authorised users
Literature
1.
go back to reference Dubois B, Hampel H, Feldman HH, Scheltens P, Aisen P, Andrieu S, Bakardjian H, Benali H, Bertram L, Blennow K, et al. Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria. Alzheimers Dement. 2016;12(3):292–323.CrossRefPubMed Dubois B, Hampel H, Feldman HH, Scheltens P, Aisen P, Andrieu S, Bakardjian H, Benali H, Bertram L, Blennow K, et al. Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria. Alzheimers Dement. 2016;12(3):292–323.CrossRefPubMed
2.
go back to reference Karran E, Mercken M, De Strooper B. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov. 2011;10(9):698–712.CrossRefPubMed Karran E, Mercken M, De Strooper B. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov. 2011;10(9):698–712.CrossRefPubMed
3.
go back to reference Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, et al. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. N Engl J Med. 2014;370(4):322–33.CrossRefPubMedPubMedCentral Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, et al. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. N Engl J Med. 2014;370(4):322–33.CrossRefPubMedPubMedCentral
4.
go back to reference Vandenberghe R, Rinne JO, Boada M, Katayama S, Scheltens P, Vellas B, Tuchman M, Gass A, Fiebach JB, Hill D, et al. Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials. Alzheimers Res Ther. 2016;8(1):18.CrossRefPubMedPubMedCentral Vandenberghe R, Rinne JO, Boada M, Katayama S, Scheltens P, Vellas B, Tuchman M, Gass A, Fiebach JB, Hill D, et al. Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials. Alzheimers Res Ther. 2016;8(1):18.CrossRefPubMedPubMedCentral
5.
go back to reference Epperly T, Dunay MA, Boice JL. Alzheimer disease: pharmacologic and nonpharmacologic therapies for cognitive and functional symptoms. Am Fam Physician. 2017;95(12):771–8.PubMed Epperly T, Dunay MA, Boice JL. Alzheimer disease: pharmacologic and nonpharmacologic therapies for cognitive and functional symptoms. Am Fam Physician. 2017;95(12):771–8.PubMed
6.
go back to reference Yuill N, Hollis V. A systematic review of cognitive stimulation therapy for older adults with mild to moderate dementia: an occupational therapy perspective. Occup Ther Int. 2011;18(4):163–86.CrossRefPubMed Yuill N, Hollis V. A systematic review of cognitive stimulation therapy for older adults with mild to moderate dementia: an occupational therapy perspective. Occup Ther Int. 2011;18(4):163–86.CrossRefPubMed
7.
go back to reference Clare L, Linden DE, Woods RT, Whitaker R, Evans SJ, Parkinson CH, van Paasschen J, Nelis SM, Hoare Z, Yuen KS, et al. Goal-oriented cognitive rehabilitation for people with early-stage Alzheimer disease: a single-blind randomized controlled trial of clinical efficacy. Am J Geriatr Psychiatry. 2010;18(10):928–39.CrossRefPubMed Clare L, Linden DE, Woods RT, Whitaker R, Evans SJ, Parkinson CH, van Paasschen J, Nelis SM, Hoare Z, Yuen KS, et al. Goal-oriented cognitive rehabilitation for people with early-stage Alzheimer disease: a single-blind randomized controlled trial of clinical efficacy. Am J Geriatr Psychiatry. 2010;18(10):928–39.CrossRefPubMed
8.
go back to reference Guideline watch (October 2014): practice guidline for the treatment of patients with Alzheimer's disease and other dementias. 2014. Guideline watch (October 2014): practice guidline for the treatment of patients with Alzheimer's disease and other dementias. 2014.
9.
go back to reference Graff MJ, Adang EM, Vernooij-Dassen MJ, Dekker J, Jonsson L, Thijssen M, Hoefnagels WH, Rikkert MG. Community occupational therapy for older patients with dementia and their care givers: cost effectiveness study. Bmj. 2008;336(7636):134–8.CrossRefPubMedPubMedCentral Graff MJ, Adang EM, Vernooij-Dassen MJ, Dekker J, Jonsson L, Thijssen M, Hoefnagels WH, Rikkert MG. Community occupational therapy for older patients with dementia and their care givers: cost effectiveness study. Bmj. 2008;336(7636):134–8.CrossRefPubMedPubMedCentral
10.
go back to reference Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Bmj. 2009;339:b2700.CrossRefPubMedPubMedCentral Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Bmj. 2009;339:b2700.CrossRefPubMedPubMedCentral
11.
go back to reference Dias S, Welton NJ, Caldwell DM, Ades AE. Checking consistency in mixed treatment comparison meta-analysis. Stat Med. 2010;29(7–8):932–44.CrossRefPubMed Dias S, Welton NJ, Caldwell DM, Ades AE. Checking consistency in mixed treatment comparison meta-analysis. Stat Med. 2010;29(7–8):932–44.CrossRefPubMed
12.
go back to reference Savovic J, Weeks L, Sterne JA, Turner L, Altman DG, Moher D, Higgins JP. Evaluation of the Cochrane Collaboration's tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation. Systematic reviews. 2014;3:37.CrossRefPubMedPubMedCentral Savovic J, Weeks L, Sterne JA, Turner L, Altman DG, Moher D, Higgins JP. Evaluation of the Cochrane Collaboration's tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation. Systematic reviews. 2014;3:37.CrossRefPubMedPubMedCentral
13.
go back to reference Sofi F, Valecchi D, Bacci D, Abbate R, Gensini GF, Casini A, Macchi C. Physical activity and risk of cognitive decline: a meta-analysis of prospective studies. J Intern Med. 2011;269(1):107–17.CrossRefPubMed Sofi F, Valecchi D, Bacci D, Abbate R, Gensini GF, Casini A, Macchi C. Physical activity and risk of cognitive decline: a meta-analysis of prospective studies. J Intern Med. 2011;269(1):107–17.CrossRefPubMed
15.
go back to reference Law LL, Barnett F, Yau MK, Gray MA. Effects of combined cognitive and exercise interventions on cognition in older adults with and without cognitive impairment: a systematic review. Ageing Res Rev. 2014;15:61–75.CrossRefPubMed Law LL, Barnett F, Yau MK, Gray MA. Effects of combined cognitive and exercise interventions on cognition in older adults with and without cognitive impairment: a systematic review. Ageing Res Rev. 2014;15:61–75.CrossRefPubMed
16.
go back to reference Heyn P, Abreu BC, Ottenbacher KJ. The effects of exercise training on elderly persons with cognitive impairment and dementia: a meta-analysis. Arch Phys Med Rehabil. 2004;85(10):1694–704.CrossRefPubMed Heyn P, Abreu BC, Ottenbacher KJ. The effects of exercise training on elderly persons with cognitive impairment and dementia: a meta-analysis. Arch Phys Med Rehabil. 2004;85(10):1694–704.CrossRefPubMed
17.
go back to reference Irazoki E, Garcia-Casal JA, Sanchez-Meca J, Franco-Martin M. Efficacy of group reminiscence therapy for people with dementia. Systematic literature review and meta-analysis. Rev Neurol. 2017;65(10):447–56.PubMed Irazoki E, Garcia-Casal JA, Sanchez-Meca J, Franco-Martin M. Efficacy of group reminiscence therapy for people with dementia. Systematic literature review and meta-analysis. Rev Neurol. 2017;65(10):447–56.PubMed
18.
go back to reference Yen HY, Lin LJ. A systematic review of reminiscence therapy for older adults in Taiwan. JNR: The journal of nursing research. 2017. Yen HY, Lin LJ. A systematic review of reminiscence therapy for older adults in Taiwan. JNR: The journal of nursing research. 2017.
19.
go back to reference Lin HC, Yang YP, Cheng WY, Wang JJ. Distinctive effects between cognitive stimulation and reminiscence therapy on cognitive function and quality of life for different types of behavioural problems in dementia. Scand J Caring Sci. 2017. https://doi.org/10.1111/scs.12484. Lin HC, Yang YP, Cheng WY, Wang JJ. Distinctive effects between cognitive stimulation and reminiscence therapy on cognitive function and quality of life for different types of behavioural problems in dementia. Scand J Caring Sci. 2017. https://​doi.​org/​10.​1111/​scs.​12484.
20.
go back to reference Hattori H, Hattori C, Hokao C, Mizushima K, Mase T. Controlled study on the cognitive and psychological effect of coloring and drawing in mild Alzheimer's disease patients. Geriatr Gerontol Int. 2011;11(4):431–7.CrossRefPubMed Hattori H, Hattori C, Hokao C, Mizushima K, Mase T. Controlled study on the cognitive and psychological effect of coloring and drawing in mild Alzheimer's disease patients. Geriatr Gerontol Int. 2011;11(4):431–7.CrossRefPubMed
21.
go back to reference Quintana-Hernandez DJ, Miro-Barrachina MT, Ibanez-Fernandez IJ, Pino AS, Quintana-Montesdeoca MP, Rodriguez-de Vera B, Morales-Casanova D, Perez-Vieitez Mdel C, Rodriguez-Garcia J, Bravo-Caraduje N. Mindfulness in the maintenance of cognitive capacities in Alzheimer's disease: a randomized clinical trial. Journal of Alzheimer's disease : JAD. 2016;50(1):217–32.CrossRefPubMed Quintana-Hernandez DJ, Miro-Barrachina MT, Ibanez-Fernandez IJ, Pino AS, Quintana-Montesdeoca MP, Rodriguez-de Vera B, Morales-Casanova D, Perez-Vieitez Mdel C, Rodriguez-Garcia J, Bravo-Caraduje N. Mindfulness in the maintenance of cognitive capacities in Alzheimer's disease: a randomized clinical trial. Journal of Alzheimer's disease : JAD. 2016;50(1):217–32.CrossRefPubMed
22.
go back to reference Niu YX, Tan JP, Guan JQ, Zhang ZQ, Wang LN. Cognitive stimulation therapy in the treatment of neuropsychiatric symptoms in Alzheimer's disease: a randomized controlled trial. Clin Rehabil. 2010;24(12):1102–11.CrossRefPubMed Niu YX, Tan JP, Guan JQ, Zhang ZQ, Wang LN. Cognitive stimulation therapy in the treatment of neuropsychiatric symptoms in Alzheimer's disease: a randomized controlled trial. Clin Rehabil. 2010;24(12):1102–11.CrossRefPubMed
23.
go back to reference Tarraga L, Boada M, Modinos G, Espinosa A, Diego S, Morera A, Guitart M, Balcells J, Lopez OL, Becker JT. A randomised pilot study to assess the efficacy of an interactive, multimedia tool of cognitive stimulation in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2006;77(10):1116–21.CrossRefPubMedPubMedCentral Tarraga L, Boada M, Modinos G, Espinosa A, Diego S, Morera A, Guitart M, Balcells J, Lopez OL, Becker JT. A randomised pilot study to assess the efficacy of an interactive, multimedia tool of cognitive stimulation in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2006;77(10):1116–21.CrossRefPubMedPubMedCentral
24.
go back to reference D'Onofrio G, Sancarlo D, Addante F, Ciccone F, Cascavilla L, Paris F, Elia AC, Nuzzaci C, Picoco M, Greco A, et al. A pilot randomized controlled trial evaluating an integrated treatment of rivastigmine transdermal patch and cognitive stimulation in patients with Alzheimer's disease. Int J Geriatr Psychiatry. 2015;30(9):965–75.CrossRefPubMed D'Onofrio G, Sancarlo D, Addante F, Ciccone F, Cascavilla L, Paris F, Elia AC, Nuzzaci C, Picoco M, Greco A, et al. A pilot randomized controlled trial evaluating an integrated treatment of rivastigmine transdermal patch and cognitive stimulation in patients with Alzheimer's disease. Int J Geriatr Psychiatry. 2015;30(9):965–75.CrossRefPubMed
25.
go back to reference Bergamaschi S, Arcara G, Calza A, Villani D, Orgeta V, Mondini S. One-year repeated cycles of cognitive training (CT) for Alzheimer's disease. Aging Clin Exp Res. 2013;25(4):421–6.CrossRefPubMed Bergamaschi S, Arcara G, Calza A, Villani D, Orgeta V, Mondini S. One-year repeated cycles of cognitive training (CT) for Alzheimer's disease. Aging Clin Exp Res. 2013;25(4):421–6.CrossRefPubMed
26.
go back to reference Ohman H, Savikko N, Strandberg TE, Kautiainen H, Raivio MM, Laakkonen ML, Tilvis R, Pitkala KH. Effects of exercise on cognition: the finnish Alzheimer disease exercise trial: a randomized, controlled trial. J Am Geriatr Soc. 2016;64(4):731–8.CrossRefPubMed Ohman H, Savikko N, Strandberg TE, Kautiainen H, Raivio MM, Laakkonen ML, Tilvis R, Pitkala KH. Effects of exercise on cognition: the finnish Alzheimer disease exercise trial: a randomized, controlled trial. J Am Geriatr Soc. 2016;64(4):731–8.CrossRefPubMed
27.
go back to reference Duru Asiret G, Kapucu S. The effect of reminiscence therapy on cognition, depression, and activities of daily living for patients with Alzheimer disease. J Geriatr Psychiatry Neurol. 2016;29(1):31–7.CrossRefPubMed Duru Asiret G, Kapucu S. The effect of reminiscence therapy on cognition, depression, and activities of daily living for patients with Alzheimer disease. J Geriatr Psychiatry Neurol. 2016;29(1):31–7.CrossRefPubMed
28.
go back to reference Van BP, Van GR, Tolson D, Wouters K, Engelborghs S, Van der Mussele S. Effects of SolCos model-based individual reminiscence on older adults with mild to moderate dementia due to Alzheimer disease: a pilot study. Journal of the American Medical Directors Association. 2013;14(7):528.e529–13. Van BP, Van GR, Tolson D, Wouters K, Engelborghs S, Van der Mussele S. Effects of SolCos model-based individual reminiscence on older adults with mild to moderate dementia due to Alzheimer disease: a pilot study. Journal of the American Medical Directors Association. 2013;14(7):528.e529–13.
29.
go back to reference Venturelli M, Scarsini R, Schena F. Six-month walking program changes cognitive and ADL performance in patients with Alzheimer. American journal of Alzheimer's disease and other dementias. 2011;26(5):381–8.CrossRefPubMed Venturelli M, Scarsini R, Schena F. Six-month walking program changes cognitive and ADL performance in patients with Alzheimer. American journal of Alzheimer's disease and other dementias. 2011;26(5):381–8.CrossRefPubMed
Metadata
Title
Psychosocial interventions for Alzheimer’s disease cognitive symptoms: a Bayesian network meta-analysis
Authors
Yuting Duan
Liming Lu
Juexuan Chen
Chunxiao Wu
Jielin Liang
Yan Zheng
Jinjian Wu
Peijing Rong
Chunzhi Tang
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2018
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-018-0864-6

Other articles of this Issue 1/2018

BMC Geriatrics 1/2018 Go to the issue